argenx announces Annual General Meeting of Shareholders on May 7, 2019
(WorldNews Netherlands)

March 26, 2019 Breda, the Netherlands - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, today announced that an annual general meeting of shareholders will be held at 9:00 a.m. CET on Tuesday May 7, 2019 at the Hilton Amsterdam Airport Schiphol, Schiphol Boulevard 701, 1118 BG Schiphol, the Netherlands. The shareholders and all other persons with meeting rights are invited to attend the annual general meeting of shareholders. The formal notice of convocation (including information on attending the meeting in person or by proxy,...